The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332305 · Cited by 2,439
Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A., & Miller, T. P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304083281404 · Cited by 2,149
Modelling for Survival Data in Medical Research
(1995) · Technometrics · doi:10.1080/00401706.1995.10485920 · Cited by 2,145
A Handbook of Statistical Analyses Using SPSS
Landau, S., & Everitt, B. S. (2003) · Chapman & Hall/CRC eBooks · doi:10.1201/9780203009765 · Cited by 1,036
Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes
Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., Wechser, M. A., Tibshirani, R., Botstein, D., & Levy, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032520 · Cited by 911
Modelling Survival Data in Medical Research
(2004) · Technometrics · doi:10.1198/tech.2004.s817 · Cited by 430
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., & Verhoef, G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf256 · Cited by 410
Modelling Survival Data in Medical Research (2nd ed.) (Book)
Cowles, M. K. (2004) · Quarterly Publications of the American Statistical Association · Cited by 369
Römer, W., Hanauske, A.-R., Ziegler, S. I., Thödtmann, R., Weber, W., Fuchs, C., Enne, W., Herz, M., Nerl, C., Garbrecht, M., et al. (1998) · PubMed · doi:10.1182/blood.v91.12.4464 · Cited by 335
Belhocine, T., Steinmetz, N. D., Hustinx, R., Bartsch, P., Jérusalem, G., Seidel, L., Rigo, P., & Green, A. M. (2002) · PubMed · Cited by 311
Barrans, S. L., Carter, I., Owen, R. G., Davies, F. E., Patmore, R. D., Haynes, A. P., Morgan, G. J., & Jack, A. S. (2002) · Blood · doi:10.1182/blood.v99.4.1136 · Cited by 276
Mikhaeel, N. G., Timothy, A. R., O’Doherty, M. J., Hain, S. F., & Maisey, M. N. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009113384 · Cited by 248
Self-citationResidual mass in lymphoma may not be residual disease.
Canellos, G. P. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.6.931 · Cited by 220
(1969) · Radiology · doi:10.1148/23.1.186b · Cited by 220
Jerusalem, G., Beguin, Y. P., Fassotte, M., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000) · PubMed · Cited by 203
Armitage, J. O., Weisenburger, D. D., Hutchins, M., Moravec, D. F., Dowling, M., Sorensen, S., Mailliard, J., Okerbloom, J., Johnson, P. S., & Howe, D. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.2.160 · Cited by 164
Kaiser, U., Uebelacker, I., Abel, U. R., Birkmann, J., Trümper, L. H. P., Schmalenberg, H., Karakas, T., Metzner, B., HOSSFELD, D. K., Bischoff, H. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.075 · Cited by 139
Hoekstra, O. S., Ossenkoppele, G. J., Golding, R. P., van Lingen, A., Visser, G. W. M., Teule, G. J. J., & Huijgens, P. C. (1993) · PubMed · Cited by 108
Current approaches to the management of non-Hodgkin's lymphoma.
Vose, J. M. (1998) · PubMed · Cited by 74
Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy.
Front, D., Bar-Shalom, R., Mor, M., Haim, N., Epelbaum, R., Frenkel, A., Gaitini, D., Kolodny, G., & Israel, O. (1999) · Radiology · doi:10.1148/radiology.210.2.r99fe07487 · Cited by 74
Current Treatment Options in Aggressive Lymphoma
Marcus, R. E. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001616926 · Cited by 21
Cited by
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665
Self-citationMolecular imaging in drug development
Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
Self-citation
Metadata
- Authors
- Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 16
- Issue
- 9
- Pages
- 1514-1523
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2152345349
- Cited by
- 401
- References
- 24
- FWCI
- 20.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.